Controllable delivery of hydrophilic and hydrophobic drugs from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats.

Co-delivery of several drugs has been regarded as an alternative strategy for achieving enhanced therapeutic effect. In this study, a co-delivery system based on the electrospun poly(lactic-co-glycolic acid) (PLGA)/mesoporous silica nanoparticles (MSNs) composite mat was designed for the co-encapsulation and prolonged release of one hydrophilic and one hydrophobic drug simultaneously. MSNs were chosen to load the hydrophobic model drug fluorescein (FLU) and hydrophilic model drug rhodamine B (RHB), respectively (named as RHB-loaded MSNs and FLU-loaded MSNs). Two kinds of drug-loaded MSNs were incorporated into the polymer matrix to form a fibrous structure by blending electrospinning. The effect of the weight ratios for the two kinds of drug-loaded MSNs and the initial PLGA concentrations on the drug release kinetics were systematically investigated. The results showed that both model drugs RHB and FLU maintained sustained delivery with controllable release kinetics during the releasing period, and the release kinetics was closely dependent on the loading ratios of two drug-loaded MSNs and the initial PLGA concentrations in the composite mats. The results suggest that the co-drug delivery system may be used for wound dressing that requires the combined therapy of several kinds of drugs.

[1]  P. Supaphol,et al.  Drug-loaded electrospun mats of poly(vinyl alcohol) fibres and their release characteristics of four model drugs , 2006 .

[2]  Yufang Zhu,et al.  Preparation of novel hollow mesoporous silica spheres and their sustained-release property , 2005 .

[3]  Cato T Laurencin,et al.  Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.

[4]  U. Gopp,et al.  Release of gentamicin from bone regenerative materials: an in vitro study. , 2007, Journal of biomedical materials research. Part B, Applied biomaterials.

[5]  Eyal Zussman,et al.  Experimental investigation of the governing parameters in the electrospinning of polymer solutions , 2004 .

[6]  Lei Xing,et al.  pH-responsive mitoxantrone (MX) delivery using mesoporous silica nanoparticles (MSN) , 2011 .

[7]  Shilun Qiu,et al.  Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica , 2006 .

[8]  Yi Yan Yang,et al.  Self-assembled polymer nanostructures for delivery of anticancer therapeutics , 2009 .

[9]  J. Xue,et al.  PLGA/mesoporous silica hybrid structure for controlled drug release. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Joachim Kohn,et al.  Electrospun nanofibrous polymeric scaffold with targeted drug release profiles for potential application as wound dressing. , 2008, International journal of pharmaceutics.

[11]  Y. Luqmani.  Mechanisms of Drug Resistance in Cancer Chemotherapy , 2005, Medical Principles and Practice.

[12]  V. Rives,et al.  Influence of the inorganic matrix nature on the sustained release of naproxen , 2010 .

[13]  A. Yarin,et al.  Mechanistic examination of protein release from polymer nanofibers. , 2009, Molecular pharmaceutics.

[14]  M. Vallet‐Regí,et al.  A New Property of MCM-41: Drug Delivery System , 2001 .

[15]  Siling Wang,et al.  Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Oualid Hamdaoui,et al.  Influence of bicarbonate and carbonate ions on sonochemical degradation of Rhodamine B in aqueous phase. , 2010, Journal of hazardous materials.

[17]  Yi Yan Yang,et al.  The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles. , 2009, Biomaterials.

[18]  R. Sachs,et al.  Cancer drug resistance: the central role of the karyotype. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[19]  Young-Seak Lee,et al.  Fluorination of electrospun hydrogel fibers for a controlled release drug delivery system. , 2010, Acta biomaterialia.

[20]  William R. Dichtel,et al.  Enzyme-responsive snap-top covered silica nanocontainers. , 2008, Journal of the American Chemical Society.

[21]  Chun Gwon Park,et al.  A nanofibrous sheet-based system for linear delivery of nifedipine. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[22]  W. A. Ivancic,et al.  Development and evaluation of a quantitative video-fluorescence imaging system and fluorescent tracer for measuring transfer of pesticide residues from surfaces to hands with repeated contacts. , 2004, The Annals of occupational hygiene.

[23]  常江.  Well-ordered mesoporous bioactive glasses(MBG):A promising bioactive drug delivery system , 2006 .

[24]  Xiaohong Li,et al.  Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation. , 2012, International journal of pharmaceutics.

[25]  J. Xue,et al.  Biodegradable polymer-silica xerogel composite microspheres for controlled release of gentamicin. , 2006, Journal of biomedical materials research. Part B, Applied biomaterials.

[26]  P. Kallinteri,et al.  Inclusion of poorly soluble drugs in highly ordered mesoporous silica nanoparticles. , 2010, International journal of pharmaceutics.

[27]  Maohong Fan,et al.  Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. , 2010, Journal of the American Chemical Society.

[28]  D. Paneva,et al.  Electrospun poly(L-lactide) membranes containing a single drug or multiple drug system for antimicrobial wound dressings , 2011 .

[29]  John Layman,et al.  Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Wenjun Meng,et al.  Hollow Mesoporous Silica/Poly(l-lysine) Particles for Codelivery of Drug and Gene with Enzyme-Triggered Release Property , 2011 .

[31]  A. B. Fuertes,et al.  Synthesis of colloidal silica nanoparticles of a tunable mesopore size and their application to the adsorption of biomolecules. , 2010, Journal of colloid and interface science.

[32]  S. Ramakrishna,et al.  Controlled release of dual drugs from emulsion electrospun nanofibrous mats. , 2009, Colloids and surfaces. B, Biointerfaces.

[33]  M. Kotaki,et al.  Systematic parameter study for ultra-fine fiber fabrication via electrospinning process , 2005 .

[34]  S. Feng,et al.  Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. , 2004, Biomaterials.

[35]  Jiang Chang,et al.  Dual drug release from electrospun poly(lactic-co-glycolic acid)/mesoporous silica nanoparticles composite mats with distinct release profiles. , 2012, Acta biomaterialia.

[36]  Murali M. Yallapu,et al.  Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. , 2010, Journal of colloid and interface science.

[37]  Shaobing Zhou,et al.  Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetanol inoculation. , 2006, Biomacromolecules.

[38]  Xin Du,et al.  Regulation role of ibuprofen toward the morphology of porous silica nanospheres during its in situ encapsulation. , 2010, Journal of colloid and interface science.

[39]  Brian G. Trewyn,et al.  Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications , 2007 .

[40]  T. Tsuruo,et al.  Drug resistance in chemotherapy for breast cancer , 2005, Cancer Chemotherapy and Pharmacology.

[41]  A. Zadhoush,et al.  Experimental investigation of the governing parameters in the electrospinning of poly(3-hydroxybutyrate) scaffolds : structural characteristics of the pores , 2010 .